Octave vs GE HealthCare
Side-by-side comparison of AI visibility scores, market position, and capabilities
Mental health care clinic network with in-network insurance coverage, San Francisco CA, raised $52M+. Hybrid virtual and in-person therapy with major payer contracts.
About
Octave is a San Francisco, California-based mental health company founded in 2018 that operates a network of mental health clinics offering therapy and psychiatric care with in-network insurance coverage from major carriers. The company has raised over $52 million and has built a hybrid model offering both in-person care at physical clinic locations and virtual therapy, enabling clients to choose the modality that works best for their needs and circumstances.\n\nOctave's business model prioritizes in-network insurance access, negotiating directly with major commercial payers including Blue Cross Blue Shield, Aetna, and Cigna to make therapy financially accessible to patients who have historically faced high out-of-pocket costs or been directed to out-of-network providers. The company handles credentialing, insurance billing, and administrative infrastructure centrally, allowing its therapists and psychiatrists to focus on clinical work rather than paperwork.\n\nThe company has expanded to multiple markets in California and New York, with plans to grow its geographic footprint. Octave serves adults with a range of mental health conditions including anxiety, depression, relationship difficulties, trauma, and life transitions. By offering in-person clinic access alongside telehealth, Octave differentiates from purely virtual mental health platforms and appeals to clients who prefer or require face-to-face care. Octave is part of the emerging category of tech-enabled mental health clinic operators alongside Mindpath Health and Two Chairs.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
About
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.